fluorodeoxyglucose f18 has been researched along with Communicable Diseases in 20 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (20.00) | 29.6817 |
| 2010's | 12 (60.00) | 24.3611 |
| 2020's | 4 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Athan, E; Bayer, AS; Chamis, AL; Dahl, A; DiBernardo, L; Durack, DT; Durante-Mangoni, E; Duval, X; Fortes, CQ; Fosbøl, E; Fowler, VG; Hannan, MM; Hasse, B; Hoen, B; Karchmer, AW; Mestres, CA; Miro, JM; Petti, CA; Pizzi, MN; Preston, SD; Roque, A; Selton-Suty, C; van der Meer, JTM; van der Vaart, TW; Vandenesch, F | 1 |
| Abu-Elhija, J; Ghanem-Zoubi, N; Haber, D; Kagna, O; Keidar, Z; Mustafa-Hellou, M; Paul, M; Qasum, M | 1 |
| Chamroonrat, W | 1 |
| Eberhard, N; Gruenig, H; Hasse, B; Huellner, MW; Husmann, L; Ledergerber, B; Messerli, M; Mestres, CA; Mueller, A; Rancic, Z; Zimmermann, A | 1 |
| Keidar, Z | 1 |
| Boni, R; Erba, PA; Lauri, C; Lazzeri, E; Signore, A; Sollini, M | 1 |
| Erba, PA; Signore, A | 1 |
| Besirli, K; Ergul, N; Kaya, A; Kaya, SY; Kilic, F; Ozaras, R; Yilmaz, MH | 1 |
| de Vries, EF; Dierckx, RA; Galli, F; Glaudemans, AW; Signore, A; Slart, RH | 1 |
| Pol, RA; Reijnen, MM; Saleem, BR; Slart, RH; Zeebregts, CJ | 1 |
| Del Sole, A; Lecchi, M; Lucignani, G | 1 |
| Ben Ali, K; Burdet, C; Joly, V; Lepage, L; Mikail, N; Pichon, M; Rouzet, F; Sarda-Mantel, L; Yazdanpanah, Y | 1 |
| Alavi, A; Bassetti, M; Carnelutti, A; Di Gregorio, F; Muser, D; Petrosillo, N; Righi, E; Werner, TJ | 1 |
| Chen, YS; Chou, YF; Hsu, YH; Lee, CF | 1 |
| Alavi, A; Basu, S | 1 |
| Bomanji, J; Haroon, A; Zumla, A | 1 |
| Love, C; Palestro, CJ | 1 |
| Belhocine, T; Brink, I; De Deyn, PP; Flamen, P; Roland, J; Van der Borght, T; Weiner, SM | 1 |
| Bleeker-Rovers, CP; Corstens, FH; Kullberg, BJ; Oyen, WJ; van der Meer, JW; Vos, FJ; Wanten, GJ | 1 |
| Alavi, A; Anand, V; Basu, S; Kumar, R; Torigian, D; Zhuang, H | 1 |
11 review(s) available for fluorodeoxyglucose f18 and Communicable Diseases
| Article | Year |
|---|---|
PET/Computed Tomography in the Evaluation of Fever of Unknown Origin and Infectious/Inflammatory Disease in Pediatric Patients.
Topics: Adolescent; Child; Communicable Diseases; Female; Fever of Unknown Origin; Fluorodeoxyglucose F18; Humans; Inflammation; Male; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2020 |
FDG PET/CT Imaging in Diabetic Patients - A Special Emphasis on Imaging of Infection.
Topics: Communicable Diseases; Diabetes Mellitus; Fluorodeoxyglucose F18; Humans; Hyperglycemia; Nuclear Medicine; Positron Emission Tomography Computed Tomography | 2018 |
Current Status of Molecular Imaging in Infections.
Topics: Communicable Diseases; Fluorodeoxyglucose F18; Humans; Molecular Imaging; Nuclear Medicine; Positron Emission Tomography Computed Tomography | 2018 |
The management and the diagnosis of fever of unknown origin.
Topics: Age Factors; Communicable Diseases; Diagnosis, Differential; Fever of Unknown Origin; Fluorodeoxyglucose F18; Humans; Neoplasms; Positron-Emission Tomography | 2013 |
The use of (18)F-FDG-PET/CT for diagnosis and treatment monitoring of inflammatory and infectious diseases.
Topics: Communicable Diseases; Fluorodeoxyglucose F18; Humans; Inflammation; Positron-Emission Tomography; Practice Guidelines as Topic; Radiopharmaceuticals; Tomography, X-Ray Computed | 2013 |
18F-Fluorodeoxyglucose positron emission tomography/CT scanning in diagnosing vascular prosthetic graft infection.
Topics: Blood Vessel Prosthesis; Communicable Diseases; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Prosthesis-Related Infections; Tomography, X-Ray Computed; Transplants | 2014 |
18F-Fluorodeoxyglucose positron emission tomography and infectious diseases: current applications and future perspectives.
Topics: Communicable Diseases; Endocarditis; Fluorodeoxyglucose F18; Heart Valve Prosthesis; Humans; Infections; Positron Emission Tomography Computed Tomography; Prospective Studies; Radiopharmaceuticals | 2017 |
Emerging role of FDG-PET for optimal response assessment in infectious diseases and disorders.
Topics: Communicable Diseases; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Radiography; Radiopharmaceuticals; Treatment Outcome | 2011 |
Role of fluorine 18 fluorodeoxyglucose positron emission tomography-computed tomography in focal and generalized infectious and inflammatory disorders.
Topics: Communicable Diseases; Fluorodeoxyglucose F18; Humans; Inflammation; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2012 |
Radionuclide imaging of infection.
Topics: Antibodies, Monoclonal; Communicable Diseases; Diphosphonates; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Infections; Leukocytes; Nuclear Medicine; Positron-Emission Tomography; Technetium | 2004 |
Role of modern imaging techniques for diagnosis of infection in the era of 18F-fluorodeoxyglucose positron emission tomography.
Topics: Acquired Immunodeficiency Syndrome; Bone Diseases, Infectious; Communicable Diseases; Diabetic Foot; Fever of Unknown Origin; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Prosthesis-Related Infections; Soft Tissue Infections; Treatment Outcome | 2008 |
9 other study(ies) available for fluorodeoxyglucose f18 and Communicable Diseases
| Article | Year |
|---|---|
The 2023 Duke-International Society for Cardiovascular Infectious Diseases Criteria for Infective Endocarditis: Updating the Modified Duke Criteria.
Topics: Communicable Diseases; Endocarditis; Endocarditis, Bacterial; Fluorodeoxyglucose F18; Heart Valve Prosthesis; Humans; Positron-Emission Tomography | 2023 |
Predictors of infectious foci on FDG PET/CT in Staphylococcus aureus bacteremia.
Topics: Bacteremia; Communicable Diseases; Fluorodeoxyglucose F18; Focal Infection; Humans; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Staphylococcal Infections; Staphylococcus aureus | 2023 |
Impact of unknown incidental findings in PET/CT examinations of patients with proven or suspected vascular graft or endograft infections.
Topics: Aged; Blood Vessel Prosthesis; Blood Vessels; Communicable Diseases; Female; Fluorodeoxyglucose F18; Humans; Incidental Findings; Male; Middle Aged; Plastic Surgery Procedures; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Vascular Grafting; Vascular Surgical Procedures | 2021 |
Editorial: Molecular Imaging of Inflammation/Infection: The Future of Disease Management.
Topics: Communicable Diseases; Fluorodeoxyglucose F18; Humans; Inflammation; Molecular Imaging; Nuclear Medicine; Positron Emission Tomography Computed Tomography | 2018 |
Variability of [18F]FDG administered activities among patients undergoing PET examinations: an international multicenter survey.
Topics: Communicable Diseases; Fluorodeoxyglucose F18; Health Care Surveys; Humans; Inflammation; International Agencies; Neoplasms; Nuclear Medicine; Positron-Emission Tomography; Practice Guidelines as Topic; Radiopharmaceuticals | 2016 |
18FDG-PET/CT: a useful tool for the management of patients in infectious diseases.
Topics: Adult; Aged; Aged, 80 and over; Communicable Diseases; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Young Adult | 2017 |
Metastatic gallbladder cancer presenting as a gingival tumor and deep neck infection.
Topics: Communicable Diseases; Fatal Outcome; Female; Fluorodeoxyglucose F18; Gallbladder Neoplasms; Gingival Neoplasms; Humans; Middle Aged; Neck; Positron-Emission Tomography; Tomography, X-Ray Computed | 2010 |
A plea for the elective inclusion of the brain in routine whole-body FDG PET.
Topics: Brain; Brain Diseases; Brain Neoplasms; Communicable Diseases; Fluorodeoxyglucose F18; Humans; Inflammation; Limbic Encephalitis; Positron-Emission Tomography; Practice Guidelines as Topic; Practice Patterns, Physicians'; Radiopharmaceuticals; Whole-Body Counting | 2005 |
18F-FDG PET in detecting metastatic infectious disease.
Topics: Adult; Aged; Candidiasis; Communicable Diseases; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Streptococcal Infections | 2005 |